BURNABY, BC — Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce… Read More
ROCKVILLE, Md. & EDMONTON, AB — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announced that the Company’s collaboration partner, Otsuka Pharmaceutical Ltd., filed a new drug application (NDA)… Read More
Lack of OHE-specific diagnostic code in hospitals may increase risk of additional cost, length of hospitalization and additional burdens for patients compared to those with a previous primary OHE diagnosis… Read More
The launch of Maquet Corin brings Getinge a step forward in two important areas. In addition to being the company´s first connected OR table, it also pioneers a modular approach… Read More
ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, announces the launch of GMP grade DLL4. GMP grade DLL4 is the first recombinant Delta-like… Read More
